STOCK TITAN

Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
AI

Clarivate (NYSE:CLVT) has announced the beta launch of its AI-powered Regulatory Assistant within the Cortellis Regulatory Intelligence platform. The new tool, set for full release in September, aims to help regulatory professionals in biopharma, medtech, and research organizations navigate complex global requirements more efficiently.

The AI Assistant features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. The solution has been developed with input from industry partners, including Moderna, and builds on Clarivate's 30+ years of regulatory expertise and proven AI platform that powers other solutions like Web of Science.

Clarivate (NYSE:CLVT) ha annunciato il lancio in beta del suo Assistente Normativo basato sull'IA all'interno della piattaforma Cortellis Regulatory Intelligence. Il nuovo strumento, previsto per il rilascio completo a settembre, mira ad aiutare i professionisti regolatori nei settori biofarmaceutico, medtech e nelle organizzazioni di ricerca a districarsi in modo più efficiente tra i complessi requisiti normativi globali.

Le funzionalità dell'Assistente IA includono IA conversazionale con risposte referenziate, cronologia chat e capacità multilingue. La soluzione è stata sviluppata con il contributo di partner del settore, tra cui Moderna, e si basa sui oltre 30 anni di esperienza regolatoria di Clarivate e sulla sua piattaforma IA collaudata che alimenta altre soluzioni come Web of Science.

Clarivate (NYSE:CLVT) ha anunciado el lanzamiento beta de su Asistente Regulatorio impulsado por IA dentro de la plataforma Cortellis Regulatory Intelligence. La nueva herramienta, con lanzamiento completo previsto para septiembre, pretende ayudar a los profesionales regulatorios de biofármacos, medtech y organizaciones de investigación a navegar con mayor eficiencia los complejos requisitos globales.

El asistente IA incluye IA conversacional con respuestas referenciadas, historial de chat y capacidades multilingües. La solución se ha desarrollado con aportes de socios del sector, entre ellos Moderna, y se apoya en los más de 30 años de experiencia regulatoria de Clarivate y en su plataforma de IA probada que impulsa otras soluciones como Web of Science.

Clarivate (NYSE:CLVT)가 Cortellis Regulatory Intelligence 플랫폼 내에서 AI 기반 규제 보조인의 베타 버전을 발표했습니다. 이 도구는 9월 정식 출시를 목표로 하며, 바이오파마·메드테크 및 연구 기관의 규제 담당자가 복잡한 글로벌 규제 요건을 보다 효율적으로 파악하도록 돕는 것을 목적으로 합니다.

AI 보조인의 기능에는 참고 출처가 포함된 대화형 AI 응답, 채팅 기록 기능 및 다국어 지원이 포함됩니다. 이 솔루션은 Moderna를 포함한 업계 파트너들의 의견을 반영해 개발되었으며, Clarivate의 30년 이상의 규제 전문성과 Web of Science 등 다른 솔루션을 뒷받침하는 검증된 AI 플랫폼을 기반으로 합니다.

Clarivate (NYSE:CLVT) a annoncé le lancement en version bêta de son Assistant réglementaire alimenté par l'IA au sein de la plateforme Cortellis Regulatory Intelligence. Le nouvel outil, dont la sortie complète est prévue en septembre, vise à aider les professionnels de la réglementation dans la biopharmacie, la medtech et les organismes de recherche à mieux s'y retrouver face aux exigences mondiales complexes.

Les fonctionnalités de l'Assistant IA incluent une IA conversationnelle avec réponses référencées, l'historique des conversations et des capacités multilingues. La solution a été développée avec l'apport de partenaires du secteur, dont Moderna, et s'appuie sur plus de 30 ans d'expertise réglementaire de Clarivate ainsi que sur sa plateforme IA éprouvée qui alimente d'autres solutions comme Web of Science.

Clarivate (NYSE:CLVT) hat die Beta-Einführung seines KI-gestützten Regulierungsassistenten innerhalb der Cortellis Regulatory Intelligence Plattform angekündigt. Das neue Tool, das im September vollständig veröffentlicht werden soll, zielt darauf ab, Regulierungsfachkräfte in der Biopharma-, Medizintechnik- und Forschungsbranche dabei zu unterstützen, komplexe globale Anforderungen effizienter zu bewältigen.

Zu den Funktionen des KI-Assistenten gehören konversationelle KI mit referenzierten Antworten, Chatverlaufsfunktionen und Mehrsprachigkeit. Die Lösung wurde mit Beiträgen von Branchenpartnern, darunter Moderna, entwickelt und baut auf Clarivates über 30-jähriger Regulierungsexpertise sowie der erprobten KI-Plattform auf, die auch andere Lösungen wie Web of Science unterstützt.

Positive
  • Integration of AI technology to streamline regulatory compliance workflows
  • Partnership with major industry players like Moderna for beta testing
  • Built on established Clarivate AI platform with 30+ years of regulatory expertise
Negative
  • None.

Insights

Clarivate's new AI Regulatory Assistant strengthens its competitive position in life sciences intelligence, potentially boosting recurring revenue from subscription upgrades.

Clarivate's beta launch of an AI-powered Regulatory Assistant within its Cortellis Regulatory Intelligence platform represents a strategic enhancement to one of its core product offerings. The timing is particularly relevant as regulatory teams across pharma and medtech face increasing complexity in global compliance requirements. This AI capability directly addresses significant pain points in regulatory workflows - specifically the time-consuming process of searching through vast regulatory databases and interpreting complex requirements.

The product incorporates several valuable capabilities that differentiate it in the market: conversational AI with referenced answers, persistent conversation history, and multilingual support. These features align with enterprise demands for more efficient regulatory intelligence tools. Importantly, the solution is built on Clarivate's existing AI infrastructure that powers other products like Web of Science, suggesting efficient R&D resource allocation rather than building from scratch.

Endorsement from Moderna, a high-profile customer, provides external validation and indicates potential market reception. The September full release timeline suggests confidence in the technology's readiness. For Clarivate's business model, which relies heavily on recurring subscription revenue, this enhancement could strengthen customer retention while potentially enabling premium pricing or upselling opportunities for the enhanced Cortellis platform. This aligns with the broader industry trend of embedding AI capabilities into enterprise software to improve stickiness and justify subscription increases.

Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease

LONDON, Aug. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the beta launch of its AI-powered Regulatory Assistant within Cortellis Regulatory Intelligence. This new capability is designed to help regulatory professionals navigate complex and evolving global requirements with greater ease, speed and confidence. Informed by customer input and tested with industry partners, the beta version of the Regulatory Assistant is built to meet the real-world needs of regulatory professionals across biopharma, medtech and research organizations. The Regulatory Assistant will be launched to all Cortellis Regulatory Intelligence users in September with additional capabilities designed to further enhance usability, personalization and decision support.

Features within the Beta version of Cortellis Regulatory Intelligence AI Assistant include:

  • Conversational AI with referenced answers: Users can ask regulatory questions naturally and get precise, cited responses, saving hours of manual work. The AI-powered Assistant, guided by domain expertise, understands regulatory nuances to provide customers with accurate answers.
  • Your conversations, always within reach: Users can pick up right where they left off with chat history, resulting in more relevant, personalized responses.
  • Multilingual by design: Search and interact in preferred languages for a seamless, tailored experience.

Yuval Kiselstein, VP, R&D, Life Sciences & Healthcare at Clarivate, said: "Today's regulatory environment is increasingly complex and fast-changing. The beta launch of the Regulatory Assistant is a key milestone in our mission to empower regulatory teams with intuitive, AI-driven tools that enhance productivity and support confident, compliant decision-making. By working closely with our Collaborative Partners, we are building a solution that reflects real-world workflows and priorities."

Janeen Skutnik-Wilkinson, Director, Regulatory Intelligence & External Engagement, Moderna, said: "We are so pleased to be a part of the beta testing for the new AI Regulatory assistant. This tool will save us significant time and resources compared to searching manually, and we are already seeing how this will speed up internal enquiries and intelligence work. We have been impressed with how the team is actively engaging clients in the development process by seeking out and acting upon our feedback to continually improve the product. They are dedicated to building a useful tool that meets our needs while ensuring that it is also accurate and user-friendly."

With market-leading intelligence solutions, transformative data technologies and trusted AI, Clarivate equips customers with the insight and foresight they need across every stage of the product lifecycle, from early discovery through commercialization and beyond. In line with this commitment, the new AI-powered Regulatory Assistant brings the Clarivate mission to life by helping customers navigate complexity, accelerate decision-making and shape the future of healthcare.

As regulatory professionals face mounting pressure to keep pace with global changes, interpret complex requirements, and ensure compliance, the Regulatory Assistant streamlines access to trusted intelligence, enabling faster, more confident decisions. Built on the same proven Clarivate AI platform that powers Clarivate solutions, including Web of Science, and trusted by hundreds of organizations, it combines powerful technology with 30+ years of regulatory expertise relied on by top pharma and global agencies.

To learn more about the Cortellis Regulatory Intelligence AI-powered Regulatory Assistant, visit here.

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.  For more information, please visit clarivate.com 

Media Contact:

Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Clarivate
newsroom@clarivate.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-launches-ai-powered-regulatory-assistant-within-cortellis-suite-to-boost-productivity-and-ease-regulatory-burden-302529012.html

SOURCE Clarivate Plc

FAQ

What is Clarivate's new AI-powered Regulatory Assistant and when will it be available?

Clarivate's AI-powered Regulatory Assistant is a tool within Cortellis Regulatory Intelligence that helps regulatory professionals navigate global requirements. It's currently in beta and will be fully launched in September 2025.

What are the key features of Clarivate's new AI Regulatory Assistant?

The key features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. It provides precise, cited responses to regulatory questions.

How does Clarivate's AI Regulatory Assistant benefit pharmaceutical companies?

The AI Assistant helps regulatory teams save significant time and resources by providing quick access to regulatory information, streamlining internal inquiries, and supporting confident, compliant decision-making.

Who is involved in testing Clarivate's new AI Regulatory Assistant?

Moderna is among the beta testing partners, with their Director of Regulatory Intelligence confirming improved efficiency in handling internal inquiries and intelligence work.

What technology powers Clarivate's AI Regulatory Assistant?

The Assistant is built on the same proven Clarivate AI platform that powers Web of Science, combining advanced technology with over 30 years of regulatory expertise.
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Latest News

CLVT Latest SEC Filings

CLVT Stock Data

2.64B
351.73M
16.72%
92.93%
5.77%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United Kingdom
ST. HELIER